Responses
Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
2 Nilogen oncosystems’s 3D-PREDICT tumoroid model is an ex vivo precision oncology and co-clinical trial enrichment platform
Compose a Response to This Article
Other responses
No responses have been published for this article.
